§ Funding Round
Series C funding round for Vividion Therapeutics raising $140M in February 2021
Series C funding round for Vividion Therapeutics raising $140M in February 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Avoro Capital Advisors | — | — |
| Organization | — | |
Aaron DavisLEAD | — | — |
BVF Partners | — | — |
| Organization | — | |
| Organization | — | |
graham walmsleyLEAD | Angel | graham walmsley |
| Organization | — | |
| Organization | — | |
Surveyor Capital | — | — |
T. Rowe Price Associates | — | — |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$272M
Top Valuation
-
Vividion Therapeutics raised $140M in a Series C round.
The round was announced on 02/01/21.
The round was led by Aaron Davis, graham walmsley.
